Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05813587
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2023-04-10
Brief Title:
To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19
Sponsor:
Organization:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd